ObjectiveSome patients with significant arteriosclerosis of the heart are not amenable to revascularization of a coronary artery because they have a combination of microangiopathy and significant macroangiopathy. We investigated the benefit of arterialization of a cardiac vein under these circumstances in an acute animal model.MethodsIn the hearts of 8 sheep, microspheres were injected into the left coronary artery; 60 minutes later, a stenosis of the left anterior descending artery was performed. After 45 minutes, retrograde venous revascularization was performed by sewing the left internal thoracic artery to the concomitant vein of the left anterior descending artery in a beating-heart technique. For flow reversal, the vein was ligated pr...
AbstractObjectives: Restoration of coronary blood flow by angiogenesis may offer a new approach to i...
AbstractObjectives. This study sought to test whether transmyocardial laser revascularization (TMLR)...
AbstractObjectiveWe have developed a technique for biologic coronary artery bypass grafting, which i...
ObjectiveSome patients with significant arteriosclerosis of the heart are not amenable to revascular...
Cardiac venous arterialization has been proposed as an alternative approach for myocardial revascula...
Cardiac vein arterialization is seldom applied for treating right coronary artery disease. This stud...
AbstractObjectiveWe have developed a technique for biologic coronary artery bypass grafting, which i...
AbstractObjective: Transmyocardial laser revascularization is an investigational technique for revas...
Objectives: Low patency rates of saphenous vein grafts remain a major predicament in surgical revasc...
AbstractObjectives: Vascular endothelial growth factor (VEGF), a potent angiogenic mediator, can be ...
After the initial reports on aorta-to-coronary artery bypass grafting, the evolution of this procedu...
The effectiveness of localized retrograde coronary venous perfusion (RCVP) in preventing or reversin...
Between 1970 and 1972, 54 patients with obstructive coronary artery disease had 84 saphenous vein by...
AbstractThe long-term clinical success of coronary artery bypass grafting with autologous saphenous ...
ObjectivesStrategies to recover myocardium in therapeutically unresponsive patients are again under ...
AbstractObjectives: Restoration of coronary blood flow by angiogenesis may offer a new approach to i...
AbstractObjectives. This study sought to test whether transmyocardial laser revascularization (TMLR)...
AbstractObjectiveWe have developed a technique for biologic coronary artery bypass grafting, which i...
ObjectiveSome patients with significant arteriosclerosis of the heart are not amenable to revascular...
Cardiac venous arterialization has been proposed as an alternative approach for myocardial revascula...
Cardiac vein arterialization is seldom applied for treating right coronary artery disease. This stud...
AbstractObjectiveWe have developed a technique for biologic coronary artery bypass grafting, which i...
AbstractObjective: Transmyocardial laser revascularization is an investigational technique for revas...
Objectives: Low patency rates of saphenous vein grafts remain a major predicament in surgical revasc...
AbstractObjectives: Vascular endothelial growth factor (VEGF), a potent angiogenic mediator, can be ...
After the initial reports on aorta-to-coronary artery bypass grafting, the evolution of this procedu...
The effectiveness of localized retrograde coronary venous perfusion (RCVP) in preventing or reversin...
Between 1970 and 1972, 54 patients with obstructive coronary artery disease had 84 saphenous vein by...
AbstractThe long-term clinical success of coronary artery bypass grafting with autologous saphenous ...
ObjectivesStrategies to recover myocardium in therapeutically unresponsive patients are again under ...
AbstractObjectives: Restoration of coronary blood flow by angiogenesis may offer a new approach to i...
AbstractObjectives. This study sought to test whether transmyocardial laser revascularization (TMLR)...
AbstractObjectiveWe have developed a technique for biologic coronary artery bypass grafting, which i...